Compared with its close competitors within the same industry, KOSDAQ, as the monthly volatility of LabGenomics had relatively expanded, the investment return for one month was negative. Over the recent month, the return-on-risk, the return on investment with consideration about risk, was -5.4%. As high volatility and a bearish stock price trend, the return-on-risk recorded a low value. However, the return-on-risk is much better than the industrial mean, -6.0, and thus the industrial comparison performance was positive.

From Sept. 8, institutions have been continuously buying LabGenomics. As a shareholding sum by investor group for the past four weeks, institutions have bought 20,705 shares with trending trade. However, during the same period, foreigners have sold 8,179 shares with maintenance of a selling position and individuals have sold 12,526 shares as they turn toward a selling stance.

By HeRo (hero@heraldcorp.com)

This article is produced by the algorithm developed by the artificial intelligence developer ThinkPool in collaboration with Herald Corp.